Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Gaynon

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|April 8, 1999
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapyF M Uckun, J B Nachman, H N Sather, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer GroupJ M Cherlow, P G Steinherz, H N Sather, et al.
Blood|July 1, 1997
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer GroupF M Uckun, H N Sather, P S Gaynon, et al.
Leukemia & Lymphoma|August 26, 1998
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group StudyF M Uckun, H N Sather, B J Waurzyniak, et al.
Blood|December 10, 1999
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer groupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106P S Gaynon, P G Steinherz, W A Bleyer, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemiaL Sun, M L Crotty, M Sensel, et al.
Leukemia & Lymphoma|February 27, 1999
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group studyF M Uckun, B J Waurzyniak, H N Sather, et al.
Cancer|April 13, 2000
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|April 8, 1999
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapyF M Uckun, J B Nachman, H N Sather, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer GroupJ M Cherlow, P G Steinherz, H N Sather, et al.
Blood|July 1, 1997
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer GroupF M Uckun, H N Sather, P S Gaynon, et al.
Leukemia & Lymphoma|August 26, 1998
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group StudyF M Uckun, H N Sather, B J Waurzyniak, et al.
Blood|December 10, 1999
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer groupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106P S Gaynon, P G Steinherz, W A Bleyer, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemiaL Sun, M L Crotty, M Sensel, et al.
Leukemia & Lymphoma|February 27, 1999
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group studyF M Uckun, B J Waurzyniak, H N Sather, et al.
Cancer|April 13, 2000
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Pageof 7